Company / Free Cash Flow per Share
Coherus Oncology, Inc. Free Cash Flow per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.39
FY2019
5-year range
-$4.47 / $0.45
FY2015-FY2019
Trend
+114.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-4.47 to $0.39 over the past 2 years.
Based on SEC 10-K filings.
0.39 in FY2019.
Improved from $-4.47 to $0.39 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, free cash flow per share increased 114.5% year-over-year.
- Peak free cash flow per share was recorded in FY2015.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.39 | +114.5% |
| FY2018 | -$2.67 | +40.2% |
| FY2017 | -$4.47 | -551.5% |
| FY2016 | -$0.69 | -251.7% |
| FY2015 | $0.45 | +110.9% |
| FY2014 | -$4.14 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026